Mimedx (MDXG) Operating Income Growth (3y) (2014 - 2026)
Mimedx (MDXG) Operating Income Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Op. Inc Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
-1,580.97% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
-29.67% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-50.81% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
16.35% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.47% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Mimedx |
534.41 Mn |
374.63 Mn |
41.62 Mn |
-261.40% |
| Date | Value |
|---|
| Mar 31, 2026 |
-261.40% |
| Dec 31, 2025 |
23.06% |
| Sep 30, 2025 |
72.40% |
| Jun 30, 2025 |
48.64% |
| Mar 31, 2025 |
42.39% |
| Dec 31, 2024 |
104.90% |
| Sep 30, 2024 |
131.35% |
| Jun 30, 2024 |
289.73% |
| Mar 31, 2024 |
57.76% |
| Dec 31, 2023 |
43.62% |
| Sep 30, 2023 |
46.53% |
| Jun 30, 2023 |
56.74% |
| Mar 31, 2023 |
70.86% |
| Dec 31, 2022 |
62.89% |
| Sep 30, 2022 |
-35.73% |
| Jun 30, 2022 |
17.36% |
| Mar 31, 2022 |
11.49% |
| Dec 31, 2021 |
28.94% |
| Sep 30, 2021 |
-69.64% |
| Jun 30, 2021 |
-30.94% |
